Annex Advisory Services LLC Grows Stock Position in Balchem Co. (NASDAQ:BCPC)

Annex Advisory Services LLC increased its stake in shares of Balchem Co. (NASDAQ:BCPC) by 28.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,537 shares of the basic materials company’s stock after acquiring an additional 1,218 shares during the period. Annex Advisory Services LLC’s holdings in Balchem were worth $974,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Bessemer Group Inc. raised its position in shares of Balchem by 568.9% in the first quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after acquiring an additional 256 shares during the period. GAMMA Investing LLC raised its holdings in Balchem by 18.0% in the 1st quarter. GAMMA Investing LLC now owns 473 shares of the basic materials company’s stock worth $73,000 after purchasing an additional 72 shares during the period. TD Asset Management Inc acquired a new stake in Balchem in the second quarter valued at approximately $200,000. Heritage Family Offices LLP purchased a new stake in shares of Balchem in the second quarter valued at approximately $206,000. Finally, Sage Rhino Capital LLC acquired a new position in shares of Balchem during the 2nd quarter worth approximately $207,000. 87.91% of the stock is currently owned by hedge funds and other institutional investors.

Balchem Price Performance

Shares of Balchem stock opened at $172.21 on Monday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. The business has a 50 day simple moving average of $170.67 and a two-hundred day simple moving average of $161.14. The stock has a market capitalization of $5.58 billion, a P/E ratio of 48.65, a PEG ratio of 5.43 and a beta of 0.65. Balchem Co. has a 12 month low of $110.74 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC) last announced its earnings results on Friday, July 26th. The basic materials company reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.03. The company had revenue of $234.08 million for the quarter, compared to analysts’ expectations of $241.26 million. Balchem had a net margin of 12.52% and a return on equity of 10.94%. As a group, analysts predict that Balchem Co. will post 3.96 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. HC Wainwright lifted their price target on shares of Balchem from $170.00 to $185.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th.

Insider Activity at Balchem

In other Balchem news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $180.05, for a total value of $1,395,387.50. Following the transaction, the senior vice president now directly owns 8,540 shares of the company’s stock, valued at $1,537,627. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.25% of the stock is owned by corporate insiders.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.